Passion and commitment coming together to innovate and accelerate pancreatic cancer research.

Passion and commitment coming together to innovate and accelerate pancreatic cancer research.

Press / Media / News

Press

Key Protein A Possible New Target in the Treatment of Pancreatic Cancer Pancreatic Cancer Collective Supports Important Study Published in Nature

(WOODBURY, N.Y., April 17, 2019) — Pancreatic cancer can be difficult to treat and often responds poorly to chemotherapy due to the presence of tumor cells located within the dense protective tissue, called the stroma. Research funded by the Pancreatic Cancer Collective, a partnership between Lustgarten Foundation and Stand Up To Cancer and guided by […]

Press

The Pancreatic Cancer Collective Funds Two New Research Teams Using Artificial Intelligence to Identify High-Risk Pancreatic Cancer Populations

Computational Tools Seek to Identify Pancreatic Cancer Earlier, Provide More Opportunities for Timely, Effective Treatments (Atlanta, GA – March 30, 2019) – The Pancreatic Cancer Collective, the strategic partnership of Lustgarten Foundation and Stand Up To Cancer (SU2C), today announced two, million-dollar grants for computational approaches to identifying high-risk pancreatic cancer populations. The grant money […]

Press

The Pancreatic Cancer Collective awards $7 million in first-round “New Therapies Challenge” Grants

The Pancreatic Cancer Collective, the strategic partnership of the Lustgarten Foundation and Stand Up To Cancer (SU2C), has awarded a total of $7 million in first-round “New Therapies Challenge” grants to seven teams of top cancer researchers to explore new pancreatic cancer treatments, the American Association for Cancer Research, the Scientific Partner of SU2C, announced […]

Press

Announcing the $25 Million Pancreatic Cancer Collective – An initiative of the Lustgarten Foundation and Stand Up To Cancer

Chicago (April 15, 2018) — The Lustgarten Foundation and Stand Up To Cancer (SU2C) announced today at the Annual Meeting of the American Association for Cancer Research, SU2C’s Scientific Partner, that they are entering into a formal strategic partnership to drive research to improve outcomes for pancreatic cancer patients. The $25 million Pancreatic Cancer Collective, […]